From Tuncurry Breakwall To Shark Beach surfline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from surfline.com Daily Mail and Mail on Sunday newspapers.
Sport Integrity Australia acknowledges the decision of Athletics Australia to sanction athlete Melanie Panayiotou for the presence and use of prohibited.
ASHLAND It almost seems like the premise of a 1980s buddy-cop flick — a recovering addict and a patrol officer teaming up to fight the opioid epidemic in their community.
(0)
-
Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive form of Non-Hodgkin s Lymphoma (NHL), representing 30-40% of cases. Nearly half of DLBCL patients are not cured by first-line treatment, leaving a large number of patients at risk of worsening disease
1
-
Naratuximab emtansine, the most advanced CD37 targeting antibody drug conjugate (ADC) in clinical development for DLBCL, showed promising safety and efficacy results in combination with rituximab for the treatment of R/R DLBCL and other B-cell malignancies
-
Phase II data presented by Dr. Moshe Yair Levy at the 2021 European Hematology Association (EHA) conference as a late breaking abstract (LB1903) demonstrated that the naratuximab emtansine/rituximab combination could represent a new treatment approach, particularly for heavily pre-treated